Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hallberg

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Endocrinology|June 25, 2019
Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical TrialShaminie J Athinarayanan, Rebecca N Adams, Sarah J Hallberg, et al.
Diabetes Research and Clinical Practice|October 21, 2024
5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension studyAmy L McKenzie, Shaminie J Athinarayanan, Michelle R Van Tieghem, et al.
JMIR Diabetes|October 7, 2018
A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 DiabetesAmy L McKenzie, Sarah J Hallberg, Brent C Creighton, et al.
BMC Musculoskeletal Disorders|March 30, 2022
Continuous care intervention with carbohydrate restriction improves physical function of the knees among patients with type 2 diabetes: a non-randomized studyKade S Lyman, Shaminie J Athinarayanan, Amy L McKenzie, et al.
Sleep Medicine|February 18, 2019
Improvement in patient-reported sleep in type 2 diabetes and prediabetes participants receiving a continuous care intervention with nutritional ketosisMorgan J Siegmann, Shaminie J Athinarayanan, Sarah J Hallberg, et al.
BMJ Open|February 27, 2019
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled studyEduardo Vilar-Gomez, Shaminie J Athinarayanan, Rebecca N Adams, et al.
Theriogenology|January 8, 2013
Evaluation of ceftiofur crystalline free acid sterile suspension for control of metritis in high-risk lactating dairy cowsC L McLaughlin, E P Stanisiewski, C A Risco, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 7, 2018
Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled StudySarah J Hallberg, Amy L McKenzie, Paul T Williams, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 9, 2018
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled StudySarah J Hallberg, Amy L McKenzie, Paul T Williams, et al.
Cancer|April 9, 2014
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesTimothy G Call, Aaron D Norman, Curtis A Hanson, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|June 25, 2019
Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical TrialShaminie J Athinarayanan, Rebecca N Adams, Sarah J Hallberg, et al.
Diabetes Research and Clinical Practice|October 21, 2024
5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension studyAmy L McKenzie, Shaminie J Athinarayanan, Michelle R Van Tieghem, et al.
JMIR Diabetes|October 7, 2018
A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 DiabetesAmy L McKenzie, Sarah J Hallberg, Brent C Creighton, et al.
BMC Musculoskeletal Disorders|March 30, 2022
Continuous care intervention with carbohydrate restriction improves physical function of the knees among patients with type 2 diabetes: a non-randomized studyKade S Lyman, Shaminie J Athinarayanan, Amy L McKenzie, et al.
Sleep Medicine|February 18, 2019
Improvement in patient-reported sleep in type 2 diabetes and prediabetes participants receiving a continuous care intervention with nutritional ketosisMorgan J Siegmann, Shaminie J Athinarayanan, Sarah J Hallberg, et al.
BMJ Open|February 27, 2019
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled studyEduardo Vilar-Gomez, Shaminie J Athinarayanan, Rebecca N Adams, et al.
Theriogenology|January 8, 2013
Evaluation of ceftiofur crystalline free acid sterile suspension for control of metritis in high-risk lactating dairy cowsC L McLaughlin, E P Stanisiewski, C A Risco, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 7, 2018
Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled StudySarah J Hallberg, Amy L McKenzie, Paul T Williams, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 9, 2018
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled StudySarah J Hallberg, Amy L McKenzie, Paul T Williams, et al.
Cancer|April 9, 2014
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesTimothy G Call, Aaron D Norman, Curtis A Hanson, et al.
Pageof 5